Lopinavir Completed Phase 4 Trials for Lipodystrophies / Cardiovascular Heart Disease / Metabolic Diseases / Glucose Metabolism Disorders / Human Immunodeficiency Virus (HIV) Infections / Dyslipidemia Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT00192621Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
NCT00619944Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir